Call Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CALL INC, and what generic and branded alternatives to CALL INC drugs are available?
CALL INC has two approved drugs.
Drugs and US Patents for Call Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Call Inc | ADAPALENE | adapalene | SOLUTION;TOPICAL | 204593-001 | Jan 5, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Call Inc | ADAPALENE | adapalene | SOLUTION;TOPICAL | 203981-001 | Sep 23, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.